🔎 Trials Near Me

Pradžia › Migrena › Arizona

Migrena klinikiniai tyrimai Arizona

10 tyrimai dėl Migrena ieško dalyvių vietose Arizona.

Miestai Arizona

Oficialus tyrimo tekstas (anglų kalba)

Study of EVO756 in Adults With Migraine

  • Trialsphere Corp, Chandler
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07616128

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Perseverance Research Center, LLC, Scottsdale
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Perseverance Research Center, LLC, Scottsdale
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04649242

Responding With Evidence and Access for Childhood Headaches

  • Phoenix Children's Hospital - Barrow Neurological Institute, Phoenix
Renkami dalyviai
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-09-21 · NCT05889624

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

  • Mayo Clinic in Arizona, Phoenix
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06401642

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Northern Arizona Healthcare, Flagstaff
  • Mayo Clinic Arizona, Phoenix
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Velocity Clinical Research - Phoenix /ID# 274478, Phoenix
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-14 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • TrialSphere, Chandler
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07645924

Determining the Utility of a Behavioral Intervention in Chronic Migraine

  • Mayo Clinic, Phoenix
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-08 · NCT05415020

Light Exposure, Migraine Outcomes, and Sleep Quality

  • ASU DeSmart Lab, Tempe
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-28 · NCT07476053

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.